Souzan Najafi

Cited by

	All	Since 2019
Citations	682	681
h-index	14	14
i10-index	15	15

240

120

180

2020202120222023202419 136 203 230 93

Public access

View all

0 articles

1 article

available

not available

Based on funding mandates

Co-authors

behzad baradaranImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
Behzad MansooriThe Wistar Institute, Cellular and molecular oncogenesis Program, Philadelphia, PA, USAVerified email at wistar.org
Ali MohammadiUniversity of Southern Denmark & Immunology Research center, Tabriz university of Medical SciencesVerified email at health.sdu.dk
Zahra AsadzadehImmunology Research Center,Tabriz University of Medical Sciences, Tabriz, IranVerified email at tbzmed.ac.ir
Afshin DerakhshaniUniversity of CalgaryVerified email at ucalgary.ca
Amir BaghbanzadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, IranVerified email at tbzmed.ac.ir
Basira NajafzadehImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
prof. Nicola Silvestris - Full Professor i...Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, ItalyVerified email at unime.it
Hossein SafarpourCellular & Molecular Research Center, Birjand University of Medical SciencesVerified email at BUMS.ac.ir
Nima HemmatPeter MacCallum Cancer Centre, University of MelbourneVerified email at petermac.org
Tohid KazemiTabriz University of Medical SciencesVerified email at tbzmed.ac.ir
Dariush Shanehbandi (Ph.D.)Tabriz university of medical sciencesVerified email at tbzmed.ac.ir
Darya JavadrashidImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
morten gjerstorffUniversity of Southern DenmarkVerified email at health.sdu.dk
sanaz naghizadehUniversity Medical Center of the Johannes Gutenberg University, Mainz, GermanyVerified email at unimedizin-mainz.de
Vahid Khaze ShahgoliUniversity of Southern Denmark & Immunology Research Center of Tabriz University of Medical SciencesVerified email at health.sdu.dk
Khalil HajiasgharzadehStem Cell Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
Solmaz ShirjangThomas Jefferson UniversityVerified email at wistar.org

Souzan Najafi

Immunology Research Center, Tabriz University of Medical Sciences

Verified email at tbzmed.ac.ir

Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression ER Asl, M Amini, S Najafi, B Mansoori, A Mokhtarzadeh, A Mohammadi, ... Life sciences 278, 119499, 2021	111	2021
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV N Hemmat, Z Asadzadeh, NK Ahangar, H Alemohammad, B Najafzadeh, ... Archives of Virology 166, 675-696, 2021	81	2021
Cytotoxic T-lymphocyte antigen-4 in colorectal cancer: another therapeutic side of capecitabine A Derakhshani, S Hashemzadeh, Z Asadzadeh, MA Shadbad, ... Cancers 13 (10), 2414, 2021	66	2021
miR‐330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer B Mansoori, A Mohammadi, S Naghizadeh, M Gjerstorff, D Shanehbandi, ... Journal of cellular physiology 235 (2), 920-931, 2020	58	2020
The oncogenic potential of NANOG: An important cancer induction mediator B Najafzadeh, Z Asadzadeh, R Motafakker Azad, A Mokhtarzadeh, ... Journal of cellular physiology 236 (4), 2443-2458, 2021	49	2021
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness B Mansoori, PHG Duijf, A Mohammadi, S Najafi, E Roshani, ... Expert Opinion on Therapeutic Targets 24 (3), 255-265, 2020	47	2020
Nanog, as a key cancer stem cell marker in tumor progression P Vasefifar, R Motafakkerazad, LA Maleki, S Najafi, F Ghrobaninezhad, ... Gene 827, 146448, 2022	41	2022
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers O Kooshkaki, A Derakhshani, H Safarpour, S Najafi, P Vahedi, O Brunetti, ... International journal of molecular sciences 21 (14), 5034, 2020	39	2020
Weighted gene co-expression network analysis combined with machine learning validation to identify key modules and hub genes associated with SARS-CoV-2 infection H Karami, A Derakhshani, M Ghasemigol, M Fereidouni, ... Journal of clinical medicine 10 (16), 3567, 2021	32	2021
miR-330 regulates colorectal cancer oncogenesis by targeting BACH1 S Shirjang, B Mansoori, A Mohammadi, N Shajari, PHG Duijf, S Najafi, ... Advanced pharmaceutical bulletin 10 (3), 444, 2020	26	2020
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy Z Asadzadeh, B Mansoori, A Mohammadi, T Kazemi, A Mokhtarzadeh, ... Biomedicine & Pharmacotherapy 137, 111364, 2021	25	2021
Restoration of miR‐330 expression suppresses lung cancer cell viability, proliferation, and migration A Mohammadi, B Mansoori, PHG Duijf, E Safarzadeh, L Tebbi, S Najafi, ... Journal of cellular physiology 236 (1), 273-283, 2021	17	2021
Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction H Alemohammad, Z Asadzadeh, N Hemmat, B Najafzadeh, P Vasefifar, ... Life Sciences 260, 118337, 2020	16	2020
Coronavirus disease 2019: a brief review of the clinical manifestations and pathogenesis to the novel management approaches and treatments O Kooshkaki, A Derakhshani, AM Conradie, N Hemmat, SG Barreto, ... Frontiers in Oncology 10, 572329, 2020	16	2020
Interaction between DNA damage response and autophagy in colorectal cancer E Roshani-Asl, B Mansori, A Mohammadi, S Najafi, F Danesh-Pouya, ... Gene 730, 144323, 2020	13	2020
NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer ZA Serej, A Ebrahimi, T Kazemi, S Najafi, M Amini, P Nastarin, ... Gene 801, 145844, 2021	9	2021
The potential of B7-H6 as a therapeutic target in cancer immunotherapy A Mohammadi, S Najafi, M Amini, B Mansoori, A Baghbanzadeh, ... Life Sciences 304, 120709, 2022	7	2022
The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells B Mansoori, S Najafi, A Mohammadi, H AsadollahSeraj, P Savadi, ... Biomedicine & Pharmacotherapy 141, 111925, 2021	7	2021
Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines Z Aliyari-Serej, A Ebrahimi, T Kazemi, S Najafi, E Roshani, ... Immunopathologia Persa 6 (2), e21-e21, 2020	6	2020
The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target P Sameti, M Tohidast, M Amini, SZ Bahojb Mahdavi, S Najafi, ... Cancer Cell International 23 (1), 134, 2023	4	2023

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors